Intercure Ltd
INCR - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$41.06M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $41.06 Million |
|---|---|
| Enterprise Value | $177.60 Million |
| Earnings per Share | $-3.15 |
| Beta | 0.64 |
| Outstanding Shares | 10,137,256 |
Return
| Return on Equity | -9.01% |
|---|---|
| Return on Assets | -5.17% |
| Return on Invested Capital | -14.12% |
Valuation & Multiples
| P/E Ratio | -3.94 |
|---|---|
| PEG | 7.74 |
| Price to Sales | 0.16 |
| Price to Book Ratio | 0.1 |
| Enterprise Value to Revenue | 0.66 |
| Enterprise Value to EBIT | -2.64 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 1.03 |
| Debt to Equity | 0.46 |
Revenue Sources
No data
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.08%▲ 0.02% |
|---|---|
| Total Invested | $764,087▲ 23.66% |
| Investors Holding | 15▲ 1.00% |
About Intercure Ltd
285 employees
CEO: Alexander Rabinovitch
InterCure Ltd. operates as an investment holding company, with interests in the medical cannabis, biomedicine, life sciences, technology, and medical devices fields. It operates through the Investments in Biomed Portfolio Companies segme...